|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 37.88 USD | -4.27% |
|
-11.23% | -23.78% |
| 09-17 | Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger | MT |
| 08-03 | Supernus Pharmaceuticals, Inc. Revises Earnings Guidance for the Full Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | -4.27% | -11.23% | -23.78% | -23.87% | +19.65% | 2.2B |  | | |
- Stock Market
- Stocks
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
